News & Research

Market Overview

*15mins delayed

Daily Morning Note – 22th June 2017


Register HERE for MONDAY’s 11.15am webinar if you have not already done so.

Our webinars are an opportunity for clients, remisiers, and sales staff, to ask questions on our coverage and the market’s direction. We hope to have as many of you as possible.

In this week’s webinar, we will explain why the US dollar will head in a secular downtrend based on cycles and how Gold and Emerging Markets will benefit under a weak dollar environment..

Archived webinars available.


Straits Times Index – Daily timeframe – Bearish
• The shooting star rejection off the 3268 resistance area since 12/06/17 is forming a double top formation here as the RSI renormalizes off the 75 overbought region.
• Watch the 3188 range low closely as the break below it would cause the next wave of selling to take place where sellers aim for the 3158 support area followed by 3112.

For more information and additional disclosures, click here for full report.


24-month angiographic data: QT Vascular Ltd. has received angiographic data from 24-month follow-up of patients with De Novo lesions treated with Chocolate Heart™ as a standalone therapy. The initial six-month results were announced on 5 January 2016.

Successful tender: Singapore Press Holdings Limited together with Kajima Development Pte. Ltd. won the tender for the 99-year lease of the Land for mixed commercial and residential use at the bid price of S$1,132,000,000.

Memorandum of Agreement: SIA Engineering Company Limited has signed Memorandum of Agreement with The Boeing Company to collaborate on the provision of aircraft maintenance training services on current and new generation aircraft types, including the Next-Generation 737, 777 and 787.

Source: SGX Masnet, Phillip Securities Research

Clients of Phillip Securities can keep updated with Country Strategy and Singapore Sector Reports by logging into: > STOCKS > Research

Read the research report(s), available through the link(s) above, for complete information including important disclosures

Important Information

The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided “as is” without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.
Confidentiality Note
This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.